{
  "id" : "nasopharynx_pharyngealtonsil_84756",
  "algorithm" : "eod_public",
  "version" : "3.0",
  "name" : "Schema Discriminator 1",
  "title" : "Schema Discriminator 1: Nasopharynx/PharyngealTonsil",
  "notes" : "**Note:** A schema discriminator is used to discriminate for primary site C111: Posterior wall of nasopharynx. Code the specific site in which the tumor arose.\n\n* **00090: Nasopharynx (see code 1)**\n     Used to stage for the following primary site description: posterior wall of nasopharynx (NOS)\n\n* **00100 (HPV-Mediated (p16+)) or 00111 (Oropharyngeal Cancer or Oropharynx (p16-)) (see code 2)**\nOropharynx Staging Systems are used for the following primary site descriptions. An additional schema discriminator will be used to distinguish between the AJCC HPV-Mediated (p16+) Oropharyngeal Cancer and Oropharynx (p16-) and Hypopharynx Staging System \n  * Adenoid\n   * Pharyngeal tonsil",
  "last_modified" : "2022-08-26T13:33:17.581Z",
  "definition" : [ {
    "key" : "discriminator_1",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  }, {
    "key" : "disease",
    "name" : "Schema ID #/Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "1", "Posterior wall of nasopharynx, NOS ", "00090: Nasopharynx" ], [ "2", "Adenoid\nPharyngeal tonsil", "3927: Schema discriminator 2: Oropharyngeal p16" ], [ "", "Primary Site is NOT C111, Discriminator is not necessary", "" ] ]
}